BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 20512042)

  • 21. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
    Heger-Mahn D; Pabst G; Dienel A; Schläfke S; Klipping C
    Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of lavender oil inhalation on vital signs and anxiety: A randomized clinical trial.
    Karan NB
    Physiol Behav; 2019 Nov; 211():112676. PubMed ID: 31505191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lavender on anxiety: A systematic review and meta-analysis.
    Donelli D; Antonelli M; Bellinazzi C; Gensini GF; Firenzuoli F
    Phytomedicine; 2019 Dec; 65():153099. PubMed ID: 31655395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single-blinded, randomized pilot study evaluating the aroma of Lavandula augustifolia as a treatment for mild insomnia.
    Lewith GT; Godfrey AD; Prescott P
    J Altern Complement Med; 2005 Aug; 11(4):631-7. PubMed ID: 16131287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical lavender oil for the treatment of recurrent aphthous ulceration.
    Altaei DT
    Am J Dent; 2012 Feb; 25(1):39-43. PubMed ID: 22558691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of anxiolytic drug silexan on sleep - a narrative review.
    Seifritz E; Kasper S; Möller HJ; Volz HP; Müller WE; Eckert A; Hatzinger M
    World J Biol Psychiatry; 2022 Sep; 23(7):493-500. PubMed ID: 36259937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta-analysis.
    von Känel R; Kasper S; Bondolfi G; Holsboer-Trachsler E; Hättenschwiler J; Hatzinger M; Imboden C; Heitlinger E; Seifritz E
    Brain Behav; 2021 Apr; 11(4):e01997. PubMed ID: 33638614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Silexan oral lavender essential oil compared to inhaled lavender essential oil aromatherapy for sleep in adults: a systematic review.
    Greenberg MJ; Slyer JT
    JBI Database System Rev Implement Rep; 2018 Nov; 16(11):2109-2117. PubMed ID: 30439747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
    Bartova L; Dold M; Volz HP; Seifritz E; Möller HJ; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):51-63. PubMed ID: 35262795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The best route of administration of lavender for anxiety: a systematic review and network meta-analysis.
    Sayed AM; Morsy S; Tawfik GM; Naveed S; Minh-Duc NT; Hieu TH; Ali ZA; Shinkar A; Doheim MF; Hashan MR; Huy NT
    Gen Hosp Psychiatry; 2020; 64():33-40. PubMed ID: 32088511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers.
    Doroshyenko O; Rokitta D; Zadoyan G; Klement S; Schläfke S; Dienel A; Gramatté T; Lück H; Fuhr U
    Drug Metab Dispos; 2013 May; 41(5):987-93. PubMed ID: 23401474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Strong is the Evidence for the Anxiolytic Efficacy of Lavender?: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Kang HJ; Nam ES; Lee Y; Kim M
    Asian Nurs Res (Korean Soc Nurs Sci); 2019 Dec; 13(5):295-305. PubMed ID: 31743795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic differences in temperament determine whether lavender oil alleviates or exacerbates anxiety in sheep.
    Hawken PA; Fiol C; Blache D
    Physiol Behav; 2012 Mar; 105(5):1117-23. PubMed ID: 22192707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
    Mahableshwarkar AR; Jacobsen PL; Serenko M; Chen Y
    Hum Psychopharmacol; 2014 Jan; 29(1):64-72. PubMed ID: 24424707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.